Walgreens ROE 2010-2024 | WBA

Current and historical return on equity (ROE) values for Walgreens (WBA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Walgreens ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-08-31 $-8.64B $12.01B -49.32%
2024-05-31 $-5.81B $15.26B -26.92%
2024-02-29 $-6.04B $15.19B -24.04%
2023-11-30 $0.57B $27.59B 2.00%
2023-08-31 $-3.08B $28.32B -11.03%
2023-05-31 $-3.32B $29.36B -11.76%
2023-02-28 $-3.14B $29.44B -11.05%
2022-11-30 $-2.96B $24.58B -10.29%
2022-08-31 $4.34B $29.37B 14.31%
2022-05-31 $5.38B $30.38B 18.61%
2022-02-28 $6.29B $30.87B 23.32%
2021-11-30 $6.43B $30.58B 26.08%
2021-08-31 $2.54B $23.82B 11.48%
2021-05-31 $2.29B $22.60B 10.65%
2021-02-28 $-0.62B $21.63B -2.92%
2020-11-30 $-0.70B $20.56B -3.19%
2020-08-31 $0.46B $21.14B 2.00%
2020-05-31 $0.76B $21.32B 3.23%
2020-02-29 $3.49B $24.33B 14.32%
2019-11-30 $3.70B $24.31B 15.02%
2019-08-31 $3.98B $24.15B 15.83%
2019-05-31 $4.82B $24.77B 18.68%
2019-02-28 $5.13B $25.41B 19.22%
2018-11-30 $5.33B $26.26B 19.44%
2018-08-31 $5.02B $26.69B 18.25%
2018-05-31 $4.31B $28.47B 15.45%
2018-02-28 $4.13B $28.18B 14.42%
2017-11-30 $3.85B $26.76B 13.15%
2017-08-31 $4.08B $28.27B 13.61%
2017-05-31 $4.31B $31.48B 14.13%
2017-02-28 $4.25B $30.42B 13.96%
2016-11-30 $4.12B $29.69B 13.59%
2016-08-31 $4.17B $30.28B 13.61%
2016-05-31 $3.17B $31.31B 10.25%
2016-02-29 $3.37B $29.92B 10.84%
2015-11-30 $4.48B $31.15B 14.29%
2015-08-31 $4.22B $31.30B 14.68%
2015-05-31 $4.00B $31.93B 15.34%
2015-02-28 $3.41B $31.03B 14.54%
2014-11-30 $2.09B $20.77B 9.97%
2014-08-31 $1.93B $20.62B 9.31%
2014-05-31 $2.88B $21.49B 14.08%
2014-02-28 $2.79B $20.83B 14.07%
2013-11-30 $2.83B $20.06B 14.61%
2013-08-31 $2.55B $19.45B 13.45%
2013-05-31 $2.15B $18.98B 11.51%
2013-02-28 $2.06B $18.97B 11.66%
2012-11-30 $1.99B $18.38B 11.95%
2012-08-31 $2.13B $18.24B 13.56%
2012-05-31 $2.57B $15.04B 17.29%
2012-02-29 $2.63B $14.82B 17.83%
2011-11-30 $2.69B $14.67B 18.25%
2011-08-31 $2.71B $14.85B 18.52%
2011-05-31 $2.39B $14.72B 16.45%
2011-02-28 $2.25B $14.68B 15.38%
2010-11-30 $2.18B $14.36B 14.84%
2010-08-31 $2.09B $14.40B 14.16%
2010-05-31 $2.06B $15.11B 13.93%
2010-02-28 $2.12B $14.95B 14.56%
2009-11-30 $2.09B $14.62B 14.68%
Sector Industry Market Cap Revenue
Retail/Wholesale Retail - Drug Stores $8.179B $147.658B
Walgreens Boots Alliance, Inc. operates as a retail drugstore chain. The Company sells prescription and non-prescription drugs, as well as general merchandise products, including household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy. Its pharmacy, health and wellness services include retail, specialty, infusion and respiratory services, mail service and convenient care clinics. The Company offers its products and services through drugstores, as well as through mail, by telephone and online. Walgreens Boots Alliance, Inc., is based in Deerfield, Illinois.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $70.208B 7.47
Herbalife (HLF) Cayman Islands $0.789B 4.16
China Jo-Jo Drugstores Holdings (CJJD) China $0.016B 0.00
GNC Holdings (GNC) United States $0.000B 0.00